Premium
Pharmaceutical regulation in Denmark and the UK: Reformulating interest representation to the transnational level
Author(s) -
GREENWOOD JUSTIN,
RONIT KARSTEN
Publication year - 1991
Publication title -
european journal of political research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.267
H-Index - 95
eISSN - 1475-6765
pISSN - 0304-4130
DOI - 10.1111/j.1475-6765.1991.tb01191.x
Subject(s) - negotiation , corporatism , internationalization , directive , state (computer science) , government (linguistics) , action (physics) , representation (politics) , private sector , public administration , civil society , political science , political economy , business , economics , international trade , law , politics , linguistics , philosophy , physics , computer science , programming language , algorithm , quantum mechanics
. Common elements are recognised across Denmark and the UK in regulation of the pharmaceutical industry, which are attributed to the impact of associational action at the sector level. Our examination of arrangements for regulating medicine prices and information displays many of the hallmarks of neo‐corporatism – namely negotiation with state agencies, compliance seeking among members, and policy implementation through acting as a Private Interest Government. During a period of economic internationalisation and directive international agencies, we show how business interests have reformulated to transnational levels, with associations, despite facing a greater complexity of interests to represent, having a strong impact upon regulatory outcomes. These have been neither wholly deregulatory or reregulatory, but partly reflect events at national levels. This may predict regulatory developments at the European level in other sectors.